Raisio plc Financial Statements Bulletin 2025

Raisio reported improved profitability in 2025 with Q4 continuing-operations net sales of EUR 55.2m (+0.6%) and comparable EBITDA of EUR 8.1m (14.6% of sales); full-year continuing net sales were EUR 224.2m (-1.1%) while comparable EBITDA rose to EUR 37.8m (16.8%) and comparable EBIT to EUR 28.5m (12.7%), lifting comparable ROIC to 11.6%. Management cited cost and pricing stabilisation amid cautious consumer demand, completed a reorganisation and divested the plant protein business, and proposed a EUR 0.15 per-share dividend; the company guides for higher net sales and comparable EBIT in 2026. Cash flow after financial items and taxes eased to EUR 27.5m (from EUR 39.3m), and management flagged continued investments (ERP, R&D, production) while shifting focus to controlled growth.

Analysis

Market structure: Raisio is a relative winner in Nordic staples by converting share in breakfast/snacks (volume +9% vs market volumetric flat through Nov) and expanding comparable EBIT margin to 12.7% (from 10.3%), signalling restored pricing power and operational leverage. Divestment of the plant-protein unit removes a growth engine but tightens focus on Benecol/Elovena where brand strength creates predictable cashflows; domestic industrial customers and grain trading are the clear losers in FY2025 revenue mix. Cross-asset: stronger profitability should depress Raisio credit spreads modestly (basis points improvement vs peers), limit downside in stock, while FX volatility (GBP/PLN) and oat/commodity inputs remain primary earnings drivers.

Risk assessment: Short-term tails include ERP implementation failure or execution cost overruns (lock-step risk: a EUR 5–10m hit would cut FY margin 200–400bp) and adverse regulatory/challenge risk to Benecol health claims. Immediate (days) market moves will be news-driven around AGM/dividend and Q1 releases; medium-term (3–12 months) risks centre on consumer-price sensitivity and pricing elasticity; long-term (2–5 years) upside depends on successful digital/production investments and market expansion in Poland/UK. Hidden dependency: concentrated brand exposure and currency translation make reported EBIT sensitive to 200–400bp FX swings.

Trade implications: Tactical long bias in Raisio (HEL:RAISIO) is warranted given margin momentum and guidance; prefer a staged 2–3% equity position with stop at -12% and 12‑month target +20–30% on modest multiple rerating. Use a conservative options sleeve: buy a 9–12 month call spread (long 25% OTM / short 50% OTM) sized to 1% portfolio to cap premium outlay while participating in upside around Q1/ERP catalysts. Rotate 2–4% from cyclical consumer discretionary into Nordic staples/food processors to capture defensiveness if macro softens.

Contrarian angles: Consensus underestimates operational gearing — a 200–300bp further margin improvement (to ~15% EBIT margin) is feasible if industrial sales stabilize and pricing reforms stick, implying upside >25% to equity value. Conversely, the market could be underpricing ERP and divestiture execution risk; if plant-protein buyers realize synergy penalties or if Benecol faces regulatory scrutiny, downside >15% is plausible. Historical parallel: smaller European FMCG restructurings typically deliver outsized EPS upgrades in years 2–3 post-restructure; monitor Q1–Q2 EBITDA conversion closely as the real inflection point.

Key Decisions for Investors

• Establish a staged long position in Raisio (HEL:RAISIO) equal to ~2.5% of portfolio within 7 trading days; add a further 2.5% only if the share price falls ≥10% from entry. Use a hard stop-loss at -12% per tranche and a 12‑month target of +25% total return driven by margin expansion and dividend capture.
• Buy a cost-controlled bullish options sleeve: open a 9–12 month call spread sized to 1% of portfolio (long 25% OTM call, short 50% OTM call) to play upside from Q1 results and ERP/pricing catalysts; close on 20% gain in spread or if Raisio misses two consecutive monthly sales indicators.
• Dividend-qualified income trade: if Raisio’s dividend yield (EUR 0.15 / current price) ≥3.0%, establish a 1–2% position at least 10 trading days before AGM/ex-dividend (monitor AGM date announced); sell within 5 trading days post-ex to realize yield + avoid extended operational risk exposure.